Clinical Trials

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 30 of 125 Clinical Trials

Clinical Research Trial

SWOG S2303 Esophageal Adenocarcinoma

Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS ≥ 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE).

Doctor(s) Running This Study
Clinical Research Trial

SWOG S2206 Breast Cancer

Phase III Trial Of Neoadjuvant Durvalumab (NSC 778709) Plus Chemotherapy Versus Chemotherapy Alone For Adults With MammaPrint High 2 Risk (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor

Doctor(s) Running This Study
Clinical Research Trial

SWOG S2206 Breast Cancer

Phase III Trial Of Neoadjuvant Durvalumab (NSC 778709) Plus Chemotherapy Versus Chemotherapy Alone For Adults With MammaPrint High 2 Risk (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor

Doctor(s) Running This Study
Clinical Research Trial

BOOMBOX: Master Study

Real-world evaluation of the HistoSonics Edison® System for treatment of liver tumors across multidisciplinary users (BOOMBOX: Master Study)

Doctor(s) Running This Study
Clinical Research Trial

BOOMBOX: Master Study

Real-world evaluation of the HistoSonics Edison® System for treatment of liver tumors across multidisciplinary users (BOOMBOX: Master Study)

Doctor(s) Running This Study
Clinical Research Trial

STML-ELA-0422

Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence—A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT)

Doctor(s) Running This Study
Clinical Research Trial

STML-ELA-0422

Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence—A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT)

Doctor(s) Running This Study
Clinical Research Trial

JCAR017-EAP-001

EXPANDED ACCESS PROTOCOL (EAP) FOR SUBJECTS RECEIVING LISOCABTAGENE MARALEUCEL THAT IS NONCONFORMING FOR COMMERCIAL RELEASE

Doctor(s) Running This Study
Clinical Research Trial

JCAR017-EAP-001

EXPANDED ACCESS PROTOCOL (EAP) FOR SUBJECTS RECEIVING LISOCABTAGENE MARALEUCEL THAT IS NONCONFORMING FOR COMMERCIAL RELEASE

Doctor(s) Running This Study